Predictions
CompuGroup Medical SE & Co. KGaA
Start price
Target price
Perf. (%)
€27.72
08.05.24
08.05.24
-
08.05.25
08.05.25
-1.23%
27.05.24
27.05.24
Heidelberger Druckmaschinen AG
Start price
Target price
Perf. (%)
€1.19
27.04.24
27.04.24
-
27.04.25
27.04.25
-
27.04.24
27.04.24
Heidelberger Druckmaschinen AG
Start price
Target price
Perf. (%)
€1.01
13.04.24
13.04.24
-
13.04.25
13.04.25
-10.57%
27.04.24
27.04.24
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€5.06
09.04.24
09.04.24
€5.00
09.04.25
09.04.25
12.75%
18.05.24
18.05.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Hypoport SE
Start price
Target price
Perf. (%)
€235.20
02.04.24
02.04.24
€166.00
02.04.25
02.04.25
-4.76%
13.04.24
13.04.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Fielmann AG
Start price
Target price
Perf. (%)
€42.55
01.04.24
01.04.24
€44.00
01.04.25
01.04.25
5.52%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€4.81
27.03.24
27.03.24
€5.00
27.03.25
27.03.25
5.24%
09.04.24
09.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€19.69
26.03.24
26.03.24
-
26.03.25
26.03.25
8.20%
04.04.24
04.04.24
Hypoport SE
Start price
Target price
Perf. (%)
€239.60
22.03.24
22.03.24
-
22.03.25
22.03.25
13.11%
06.05.24
06.05.24
Very low/no dividend yield expected
EBIT decline/stagnation expected
Instone Real Estate Group AG
Start price
Target price
Perf. (%)
€7.93
16.03.24
16.03.24
-
16.04.24
16.04.24
10.97%
17.04.24
17.04.24
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€4.53
16.03.24
16.03.24
€5.00
16.03.25
16.03.25
6.18%
27.03.24
27.03.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued